Articles tagged with "Virology"

Sort by

One drug to treat them all: towards a ‘master’ coronavirus treatment

July 22, 2021
Researchers seek and find that precious drug-binding pocket that is so essential to the coronavirus protein function that it cannot be mutated, and therefore remains accessible across all strains. Using...

New report recommends antibody testing within the Covid-19 vaccination programme

July 8, 2021
Antibody testing can be used to identify the minority of people who have a sub-optimal response to Covid-19 vaccination, this is estimated to be up to 10 per cent of...

Tackling underlying respiratory conditions for this pandemic and next

July 5, 2021
Innovation ecosystems are crucial to improving outcomes for patients with non-cystic fibrosis bronchiectasis. With a third wave of the current pandemic now seemingly inevitable and those with underlying conditions still...

Olympic Games highlights global inequity in COVID-19 vaccination progress

July 5, 2021
With the rescheduled 2020 Olympic games set for July and August this year, the low vaccination rates in Japan and the impending influx of local spectators to the events could...

Free webinar: Testing imported pets to mitigate emerging disease threats

June 9, 2021
With the demand for pets rising dramatically over lockdown, and the number of illegal imports keeping pace, the veterinary sector is concerned that the risks for zoonotic disease transmission resulting...

Staying ahead of the bacteria: A new weapon in the anti-bacterial arms race

June 1, 2021
In the perpetual arms races between bacteria and human-made antibiotics, there is a new tool to give human medicine the edge, in part by revealing bacterial weaknesses and potentially by...

Will remote clinical trials help or hinder?

May 28, 2021
With the current world focus on remote solutions, some contract services appear to benefit from place-independence. But Ellie Robertson discusses why, when looked at in greater depth, remote trials aren't...

Can immune cell-based therapies become mainstream in oncology?

May 20, 2021
Can gene editing technology help transition cell-based therapies to solid tumours? Here, Jonathan Frampton looks at the potential evolution of this currently costly approach into mainstream treatment of cancer patients...

Pin It on Pinterest